IQVIA Holdings | IQV - Sales Revenues


IQVIA Holdings reported $4.15B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Accenture USD 18B 44.07M Feb/2026
Agilent USD 1.8B 63M Dec/2025
Bruker USD 823.4M 153.8M Mar/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Celltrion KRW 1.15T 180B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cigna USD 68.52B 3.95B Mar/2026
Cognizant Technology Solutions USD 5.41B 110M Mar/2026
Computer Programs Systems USD 87.79M 3.96M Dec/2025
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
CVS Health USD 100.4B 5.3B Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 880M 81M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Elevance Health USD 49.5B 200M Mar/2026
Humana USD 39.65B 7.13B Mar/2026
IBM USD 15.92B 3.78B Mar/2026
Illumina USD 1.09B 70M Mar/2026
Infosys INR 474.3B 19.51B Mar/2026
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Laboratory Of America USD 3.54B 20M Mar/2026
McKesson USD 92.3B 13.86B Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pharma Mar EUR 42.9M 47.3M Mar/2026
Publicis EUR 3.46B 60M Dec/2025
Qiagen NV USD 419.22M 38.16M Mar/2026
Quest Diagnostics USD 2.9B 90M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Tilray USD 217.51M 74.75M Dec/2025
UnitedHealth USD 111.7B 1.5B Mar/2026
Veeva Systems USD 835.95M 24.72M Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.27B 338M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026